{
  "meta": {
    "timestamp": "2025-01-06T07:04:21.891333",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Veradigm Inc",
      "symbol": "MDRX",
      "analysis": {
        "historical": {
          "risk_score": 70,
          "key_risks": [
            "Nasdaq delisting due to non-compliance with listing rules",
            "Revenue misstatements and internal control failures",
            "Regulatory scrutiny over compliance with U.S. healthcare regulations",
            "Competitive pressures in the healthcare IT market",
            "Integration challenges with new technologies"
          ],
          "controversies": [
            "Shareholder class action lawsuit alleging revenue overstatements",
            "Suspension of trading on Nasdaq",
            "Extended term for interim CFO indicating potential financial leadership instability"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Data privacy concerns related to life sciences division expansion"
          ],
          "governance_issues": [
            "Internal control failures related to revenue recognition",
            "Potential instability in financial leadership"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Veradigm Gets Delisting Notification From Nasdaq",
              "snippet": "A Nasdaq Hearings Panel has determined to delist the common stock of the company from Nasdaq because of non-compliance issues. Trading in Veradigm's common stock will be suspended effective Feb. 29, 2024. Although the company has the right to have the decision reviewed, Veradigm said it does not intend to request that the Nasdaq Listing and ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:03:49.474798+00:00",
              "published_date": null,
              "source_hash": "db155c08f4998254fee20fc5393b2908"
            },
            {
              "url": "",
              "title": "Veradigm Receives Expected Delisting Notice from Nasdaq - Yahoo Finance",
              "snippet": "Continues to Work Diligently Towards Regaining Compliance. CHICAGO, February 28, 2024--(BUSINESS WIRE)--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:03:49.474912+00:00",
              "published_date": null,
              "source_hash": "38fffb83e85fdd7ed52c541a9fc9dc51"
            },
            {
              "url": "",
              "title": "ONC Regulatory Compliance - Veradigm",
              "snippet": "At Veradigm, we take regulatory compliance very seriously. As such, we outline below the communications guidelines that comply with the ONC's 21st Century Cures Act final rule. ... We will be happy to address any issues or questions in that way, as all Veradigm staff have undergone training on this important regulation. ONC Health IT Certified ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:03:49.474928+00:00",
              "published_date": null,
              "source_hash": "d110a5b141a0b67f68cbca2e67bce035"
            },
            {
              "url": "",
              "title": " John M. Erwin, et al. v. Veradigm Inc., et al. 23-CV-16205-Complaint ...",
              "snippet": "9. On August 18, 2023, Veradigm issued a press release announcing that it had received an additional notice of non-compliance with Nasdaq's listing requirements, and tha t it was unsure whether it could regain compliance by the September 18, 2023 deadline. 10. On September 18, 2023, Veradigm issued a press release announcing that it was again",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:03:49.474938+00:00",
              "published_date": null,
              "source_hash": "6688d2fc985a99ed9e49e8d1cabbedf8"
            },
            {
              "url": "",
              "title": "Veradigm Allegedly Misstated Revenue, Prompted Nasdaq Delisting",
              "snippet": "Veradigm Inc. and its top executives allegedly misled investors about the company's revenue figures and demand for more than two years, according to a shareholder class action complaint. The healthcare technology company allegedly failed to maintain effective internal controls over its financial reporting or to comply with appropriate revenue recognition practices, ultimately receiving a ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:55.508795+00:00",
              "published_date": null,
              "source_hash": "b254ae642f7cc0e6ed8e7a1658640642"
            },
            {
              "url": "",
              "title": "Veradigm Inc. Receives Approval from Nasdaq of Plan to Regain Listing ...",
              "snippet": "CHICAGO--(BUSINESS WIRE)--Jun. 13, 2023-- Veradigm Inc. (Nasdaq: MDRX) announced today that Nasdaq has accepted the Company's plan to regain compliance with Nasdaq Listing Rule 5250(c)(1) and granted the Company an exception until September 18, 2023 to file its Annual Report on Form 10-K for the year ended December 31, 2022 (the \"Form 10-K\") and Quarterly Report on Form 10-Q for the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:03:49.474961+00:00",
              "published_date": null,
              "source_hash": "ac98ebb760c010d608b7b084b1526cce"
            },
            {
              "url": "",
              "title": "Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc ...",
              "snippet": "If you own Veradigm stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:03:49.474971+00:00",
              "published_date": null,
              "source_hash": "acb8c20372171dd8812cb0d85d7c88c8"
            },
            {
              "url": "",
              "title": "Veradigm receives notice of delisting from Nasdaq",
              "snippet": "UPDATE: Sept. 25, 2023: Veradigm has received notice that its shares will be delisted from the Nasdaq after the health IT company failed to file required financial paperwork before the end of the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:03:49.474980+00:00",
              "published_date": null,
              "source_hash": "603798977367852781a73b1c57842cab"
            },
            {
              "url": "",
              "title": "Veradigm Inc. Announces that Nasdaq Hearings Panel has Granted its ...",
              "snippet": "CHICAGO, December 13, 2023--Veradigm Inc. (NASDAQ: MDRX (the \"Company\")) announced today that it received a decision from the Nasdaq Hearings Panel (the \"Panel\") granting its request for continued ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:03:49.474990+00:00",
              "published_date": null,
              "source_hash": "05a5600495c5c67e40e484a2f4ca1726"
            },
            {
              "url": "",
              "title": "Veradigm Inc. Announces that Nasdaq Hearings Panel has Granted its ...",
              "snippet": "Veradigm Inc. announced today that it received a decision from the Nasdaq Hearings Panel granting its request for continued listing on the Nasdaq Capital Market, subject to the Company ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:03:49.474999+00:00",
              "published_date": null,
              "source_hash": "4a7fcfd5b0eb74171ae55d761006ce21"
            },
            {
              "url": "",
              "title": "Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)",
              "snippet": "Glancy Prongay & Murray LLP (\"GPM&CloseCurlyDoubleQuote;) announces its investigation of Veradigm Inc. (OTCMKTS: MDRX) concerning the Company and its directors&CloseCurlyQuote; and officers&CloseCurlyQuote; possible violations of state laws. If you own ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:03:52.945381+00:00",
              "published_date": "2024-12-08T23:59:00+00:00",
              "source_hash": "9e3c51dbb64dffc248d3645192fcfeb1"
            },
            {
              "url": "",
              "title": "Veradigm Inc. (MDRX)",
              "snippet": "CHICAGO, November 21, 2024--Veradigm ... compliance with NASDAQ listing rules and is no longer eligible for continued inclusion in the S&P SmallCap 600. CHICAGO, February 28, 2024--Veradigm Inc ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:03:52.945430+00:00",
              "published_date": "2025-01-03T00:00:00+00:00",
              "source_hash": "d8b09d9f74ff30ff28a1a9d240041e87"
            },
            {
              "url": "",
              "title": "Veradigm interim CFO gets another term extension",
              "snippet": "Veradigm (MDRX) stock in focus as interim CFO Leland Westerfield gets his term extended until June 2025 amid leadership transition. Read more here.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:58.067926+00:00",
              "published_date": "2025-01-02T11:50:00+00:00",
              "source_hash": "6df5970aef4de7e9fab70241ad6c5764"
            },
            {
              "url": "",
              "title": "EX-99.1 - SEC.gov",
              "snippet": "Exhibit 99.1 . Veradigm Inc. Update on 4th Quarter and Full Fiscal Year 2022 Reporting of Results . CHICAGO - FEBRUARY 28, 2023 - Veradigm Inc. (NASDAQ: MDRX), announced today that in conjunction with its year-end audit procedures it has detected certain internal control failures related to revenue recognition that have occurred over the prior six quarters, resulting in a mis-statement to ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:55.508876+00:00",
              "published_date": null,
              "source_hash": "7b762f813970adfd9f68c5fd2f497c70"
            },
            {
              "url": "",
              "title": "Veradigm hit with investor class action over alleged financial ...",
              "snippet": "The lawsuit accuses Veradigm of violating federal securities laws. It accuses Veradigm of overstating historical revenues by at least $20 million and artificially inflating earnings and margins by allegedly recording duplicate transactions over two years.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:55.508892+00:00",
              "published_date": null,
              "source_hash": "b6a8a520ef3ee99ed080b23ea916f1df"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Inc. f/k/a Allscripts Healthcare Solutions, Inc. (\"Veradigm\" or the \"Company\") with the United States (\"U.S.\") Securities and Exchange Commission (\"SEC\"); (b) review and analysis of press releases and media reports issued by and disseminated by Veradigm; and (c) review of other publicly available information concerning Veradigm.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:55.508905+00:00",
              "published_date": null,
              "source_hash": "eac629898fd5927e61718562fa1928d3"
            },
            {
              "url": "",
              "title": "Veradigm (MDRX) CEO and CFO Ousted Amid Class Action Lawsuit Alleging ...",
              "snippet": "Veradigm Inc. (MDRX) Securities Fraud Class Action: On Dec. 8, 2023, Veradigm announced that as a result of its ongoing internal investigation relating to the company's financial reporting, its ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:55.508915+00:00",
              "published_date": null,
              "source_hash": "d7e435c19661a3891a87c80c7b53bf80"
            },
            {
              "url": "",
              "title": "Veradigm Inc. Faces Class Action Lawsuit: Shining Light on Alleged ...",
              "snippet": "As such, it is crucial to analyze the context in which this lawsuit is being filed and its potential implications for Veradigm's shareholders. Financial Performance Comparison: Comparing Veradigm's financial results with those of its competitors, Allscripts Healthcare Solutions Inc. reported a staggering decrease in revenue of -58.86% year on ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:55.508925+00:00",
              "published_date": null,
              "source_hash": "97515fdb1f8154dc22d1e4ada0cb0317"
            },
            {
              "url": "",
              "title": "MDRX INVESTIGATION: Robbins Geller Rudman & Dowd LLP Announces ...",
              "snippet": "THE COMPANY: Veradigm is a healthcare technology company that offers electronic health records, financial management, population health management, and consumer solutions to over 300,000 U.S ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:55.508935+00:00",
              "published_date": null,
              "source_hash": "3998c84d18124f1cd6fccd6cc7363dd9"
            },
            {
              "url": "",
              "title": "Veradigm, Inc. (NASDAQ: MDRX) Shareholder Investigation - Grabar Law Office",
              "snippet": "A securities fraud class action lawsuit alleges that Veradigm, Inc. (NASDAQ: MDRX) made false and/or misleading statements and/or failed to disclose that: (i) Veradigm had overstated its historical revenues by at least $20 million; (ii) Veradigm had artificially inflated its revenue by recording duplicate transactions, among other things, over ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:55.508944+00:00",
              "published_date": null,
              "source_hash": "b47871f55e7c02d5cc39e521c08ace16"
            },
            {
              "url": "",
              "title": "Veradigm Inc. in Crosshairs of Securities Class Action - Assessing ...",
              "snippet": "Veradigm Inc. (formerly Allscripts Healthcare Solutions Inc.) is facing a securities class action as announced by Rosen Law Firm and Bragar Eagel & Squire, P.C. Investors who purchased Veradigm common stock between February 26, 2021, and June 13, 2023 (the Class Period), have until January 22, 2024, to join the lawsuit as lead plaintiffs.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:55.508954+00:00",
              "published_date": null,
              "source_hash": "5bfca79a923180c2c6f8c89a361cd85a"
            },
            {
              "url": "",
              "title": "Veradigm Inc. - Glancy Prongay & Murray LLP",
              "snippet": "On February 28, 2023, Veradigm disclosed that it \"detected certain internal control failures related to revenue recognition that have occurred over the prior six quarters,\" re",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:55.508963+00:00",
              "published_date": null,
              "source_hash": "87a7e0f832dd14b8add72f554226e98b"
            },
            {
              "url": "",
              "title": "Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)",
              "snippet": "Glancy Prongay & Murray LLP (\"GPM\") announces its investigation of Veradigm Inc. (OTCMKTS: MDRX) concerning the Company and its directors' and officers' possible violations of state laws.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:58.067772+00:00",
              "published_date": "2024-12-09T13:58:00+00:00",
              "source_hash": "fd1cc7008f02207ec9602f7f7e167c75"
            },
            {
              "url": "",
              "title": "Veradigm (NASDAQ:MDRX) Now Covered by Analysts at StockNews.com",
              "snippet": "StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX - Free Report) in a research report report published on Saturday. The brokerage issued a hold rating on the software maker's stock. Veradigm Price Performance Shares of MDRX stock opened at $9.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:58.067869+00:00",
              "published_date": "2025-01-05T07:51:00+00:00",
              "source_hash": "c6ba886bf6727d75b99ead25073a2b54"
            },
            {
              "url": "",
              "title": "Veradigm Inc. (MDRX)",
              "snippet": "CHICAGO, May 28, 2024--Veradigm Inc. (OTCMKTS: MDRX ... Lee Westerfield, Interim Chief Financial Officer, and Will Manidis Co-Founder of ScienceIO will participate in a fireside chat at the ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:58.067900+00:00",
              "published_date": "2025-01-03T00:00:00+00:00",
              "source_hash": "a4b44024cea31c71dd9bc1f78a24048c"
            },
            {
              "url": "",
              "title": "Veradigm gains after report of bids in sales process",
              "snippet": "Veradigm (OTC:MDRX) rose 4.4% after a report about initial bids in its sales process. Veradigm (OTC:MDRX) has seen interest from private equity firm Thoma Bravo, which owns NextGen Healthcare ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Veradigm Inc Veradigm Inc financial performance controversies",
              "retrieved_at": "2025-01-06T14:03:58.067950+00:00",
              "published_date": "2024-08-12T19:17:00+00:00",
              "source_hash": "264a0d142ff9ee53b3f274dc3a412b54"
            },
            {
              "url": "",
              "title": "Customer Demographics and Target Market of Veradigm",
              "snippet": "By understanding the diverse customer demographics that Veradigm serves, the company can tailor its products and services to meet the unique needs and challenges of each segment. This customer-centric approach allows Veradigm to drive innovation, improve healthcare outcomes, and deliver value to its customers across the healthcare ecosystem.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Veradigm Inc Veradigm Inc customer retention challenges",
              "retrieved_at": "2025-01-06T14:03:59.444641+00:00",
              "published_date": null,
              "source_hash": "9a3fb15638099115829bf88e9387a158"
            },
            {
              "url": "",
              "title": "Sales and Marketing Strategy of Veradigm - CANVAS, SWOT, PESTEL & BCG ...",
              "snippet": "Furthermore, Veradigm's market niche is characterized by its focus on customization and personalization. Rather than offering one-size-fits-all solutions, Veradigm works closely with each client to understand their unique needs and challenges, and develops tailored solutions that address these specific requirements.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Veradigm Inc Veradigm Inc customer retention challenges",
              "retrieved_at": "2025-01-06T14:03:59.444665+00:00",
              "published_date": null,
              "source_hash": "75a24361ed55b21cdc0a7e3ca8b39753"
            },
            {
              "url": "",
              "title": "Veradigm Inc: Business Model, SWOT Analysis, and Competitors 2024",
              "snippet": "Discover how Veradigm Inc. is shaping the healthcare landscape in 2024 with a comprehensive analysis of its business model, SWOT insights, and competitive positioning. ... Integration Challenges: As Veradigm expands its offerings, integrating new technologies and solutions can pose challenges that may affect client satisfaction.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Veradigm Inc Veradigm Inc customer retention challenges",
              "retrieved_at": "2025-01-06T14:03:59.444670+00:00",
              "published_date": null,
              "source_hash": "705f8dea58ee973dd52a21670a25fb7a"
            },
            {
              "url": "",
              "title": "Growth Strategy and Future Prospects of Veradigm - CBM",
              "snippet": "Veradigm, a leading healthcare technology company, is setting the stage for an ambitious growth strategy and promising future prospects in the industry.With a strong focus on innovation and customer-centric solutions, Veradigm is poised to revolutionize the healthcare landscape. By leveraging cutting-edge technology and strategic partnerships, Veradigm is primed to drive significant value for ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Veradigm Inc Veradigm Inc customer retention challenges",
              "retrieved_at": "2025-01-06T14:03:59.444674+00:00",
              "published_date": null,
              "source_hash": "0d73252f198e517599184d6ba82b2342"
            },
            {
              "url": "",
              "title": "Veradigm's Challenging Outlook: Hold Rating Justified Amid Revenue ...",
              "snippet": "Veradigm (MDRX) Company Description: Allscripts Healthcare Solutions, Inc. engages in the provision of clinical, financial, connectivity, information solutions, and related professional services.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Veradigm Inc Veradigm Inc customer retention challenges",
              "retrieved_at": "2025-01-06T14:03:59.444678+00:00",
              "published_date": null,
              "source_hash": "7a9eacb22dfd5849d4944b00d712b5a5"
            },
            {
              "url": "",
              "title": "Financial Information | Investor Relations - Veradigm Inc.",
              "snippet": "The Investor Relations website contains information about Veradigm Inc.'s business for stockholders, potential investors, and financial analysts.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Veradigm Inc Veradigm Inc customer retention challenges",
              "retrieved_at": "2025-01-06T14:03:59.444681+00:00",
              "published_date": null,
              "source_hash": "aa4c55fefe313177024faded77a580a3"
            },
            {
              "url": "",
              "title": "Veradigm Inc. (MDRX) Company Profile & Overview - Stock Analysis",
              "snippet": "The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Veradigm Inc Veradigm Inc customer retention challenges",
              "retrieved_at": "2025-01-06T14:03:59.444685+00:00",
              "published_date": null,
              "source_hash": "20ded4939e087fe0542b2a3af419cc35"
            },
            {
              "url": "",
              "title": "Veradigm Inc (MDRX) Issues Refreshed Fiscal 2023 Financial Estimates",
              "snippet": "Veradigm Inc (NASDAQ:MDRX) has estimated its revenue on a GAAP basis to be between $608 million and $622 million, which includes a favorable customer litigation settlement of approximately $16 ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Veradigm Inc Veradigm Inc customer retention challenges",
              "retrieved_at": "2025-01-06T14:03:59.444688+00:00",
              "published_date": null,
              "source_hash": "9d3c14e9bd800260a25a1e6e597a314f"
            },
            {
              "url": "",
              "title": "Veradigm LLC Company Profile - GlobalData",
              "snippet": "Veradigm LLC (Veradigm), previously Allscripts Healthcare Solutions Inc, is a provider of healthcare information technology solutions. The company's key solutions include Electronic Health Records (EHR), financial management solutions, population health management solutions, and consumer solutions to help their clients.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Veradigm Inc Veradigm Inc customer retention challenges",
              "retrieved_at": "2025-01-06T14:03:59.444691+00:00",
              "published_date": null,
              "source_hash": "b9a150c18211d73fa5ee13dd422e3297"
            },
            {
              "url": "",
              "title": "VERADIGM INC. Company Profile | Atlanta, GA - Dun & Bradstreet",
              "snippet": "Find company research, competitor information, contact details & financial data for VERADIGM INC. of Atlanta, GA. Get the latest business insights from Dun & Bradstreet.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Veradigm Inc Veradigm Inc customer retention challenges",
              "retrieved_at": "2025-01-06T14:03:59.444694+00:00",
              "published_date": null,
              "source_hash": "aeb0972beeb4fea32093f9aacbcc521f"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Veradigm Inc regulatory compliance issues",
              "rationale": "Investigate potential legal and regulatory challenges related to data privacy and security",
              "priority": 1
            },
            {
              "category": "financial_legal",
              "query": "Veradigm Inc financial performance controversies",
              "rationale": "Examine concerns about revenue fluctuations and profitability",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "Veradigm Inc customer retention challenges",
              "rationale": "Explore issues related to customer satisfaction and platform transitions",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T07:04:21.891348",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}